Also published in
Mala Anand to Join Agilent’s Board of Directors
x hide permanently

Breaking News: Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb

SUMMIT, N.J.--(BUSINESS WIRE)--Apr 12, 2019--Celgene Corporation (NASDAQ: CELG) today announced that its stockholders have voted to approve the company’s proposed combination with Bristol-Myers Squibb Company (NYSE: BMY). Approximately 98% of the votes cast, and over 70% of the shares outstanding and entitled to vote, voted in favor of the transaction at the special meeting...

Mentions: acquisition Nasdaq Bristol-Myers Squibb